Adipotide FTPP 10mg Uses, Benefits, and Safety
Adipotide, referred to also as FTPP, is an experimental weight loss treatment that’s been proven to kill fat cells by starving them of blood supply so that they die and is reabsorbed into the body, as research on animals showed.
Established in 2011 by Dr. Wadih Arap and Renata Pasqualini, FTPP peptide is considered to be a diet and cancer pill.
According to research, adipotide is a new and innovative drug that is showing great promise in the area of obesity research. Initially created as cancer treated with the purpose of targeting cancer cells so that they would stop growing, Adipotide peptide has also shown promise of decreasing body weight, as studies showed.
How Adipotide Works
FTPP is a chimeric peptide. In other words, it is comprised of two components, which together affect the function of prohibitins (PHBs)[i].
Scientific studies on rats showed a 30 per cent decrease in body weight. Following four weeks of daily injections of adipotide along with four weeks without treatment, ten obese female rhesus monkeys[ii] lost approximately 11 per cent of their body weight and around 40 per cent of fat deposits. This loss was primarily experienced during the non-treatment period.
Pros and Cons of Adipotide
As per recent scientific research, there appears to be a number of benefits of Adipotide. Not only has it been shown to stimulate fat loss, research also suggests it has the ability to target and ultimately kill cancer cells by starving them of blood supply.
Let’s take a look at some of the Adipotide benefits, as well as the downsides that make it a little less appealing.
Adipotide PROS, as research showed as of June 2023:
- Extensive research has been carried out on the adipotide peptide, with promising studies
- Proven to reduce body weight and fat deposits in animal subjects
- Starves fat cells of blood supply to minimize weight gain in animals
- Weight loss continues even after the drug is discontinued, as tests in animals showed
- Adipotide can cause dehydration
- It has been shown to produce kidney lesions, in rare cases, on animals
- It is still in the testing phases
Adipotide for Weight Loss
As far back as 2011, research showed impressive Adipotide results.
According to Randy Seeley[iii], an obesity researcher at the University of Cincinnati College of Medicine, Adipotide fat loss effects include sending messages to the brain’s appetite centres to inform them that the body cannot store any more fat. In short, it’s saying: eat less.
“What they have tapped into is a whole layer of biology about how adipose tissue communicates with the brain and other organs about its status, and we didn’t know anything about that until they came along,” explained Seeley.
Side Effects of Adipotide
While studies on Adipotide look promising, there still remain concerns that must be addressed before they can be made available for consumption. For example, it was found to be ineffective in monkeys who were already slender, suggesting that the peptide may stop working once a certain body weight is reached.
Furthermore, there could be some potentially dangerous side effects, including dehydration and small kidney lesions, as tests in animals showed.
Overall, it is considered a breakthrough drug in weight loss treatment, but research must be continued on this peptide drug prior to selling it on the market for usage. Atm it is only for legal research purposes.
Buy Adipotide Online 2023
You can buy Adipotide 10mg online directly from Peptidesciences.com, a trusted supplier of peptide products. U.S.A manufactured and of the highest purity, buying FTPP has never been easier or safer. Always make sure you buy adipotide from a reputable provider.
Author info and References
Author info: The information provided in this article was taken from studies carried out by recognized researchers, including Frédéric Thuaud, Nigel Ribeiro, Canan G.Nebigil, Laurent Désaubry, Kirstin F. Barnhart, Dawn R. Christianson, Patrick W. Hanley, Wouter H. P. Driessen, Bruce J. Bernacky, Wallace B. Baze, Sijin Wen, Mei Tian, Jingfei Ma, Mikhail G. Kolonin, Pradip K. Saha, Kim-Anh Do, James F. Hulvat, Juri G. Gelovani, Lawrence Chan, Wadih Arap, Renata Pasqualini, and Randy Seeley.
[i] “Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential,” Frédéric Thuaud, Nigel Ribeiro, Canan G.Nebigil, Laurent Désaubry: https://doi.org/10.1016/j.chembiol.2013.02.006
[ii] “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys,” Kirstin F. Barnhart, Dawn R. Christianson, Patrick W. Hanley, Wouter H. P. Driessen, Bruce J. Bernacky, Wallace B. Baze, Sijin Wen, Mei Tian, Jingfei Ma, Mikhail G. Kolonin, Pradip K. Saha, Kim-Anh Do, James F. Hulvat, Juri G. Gelovani, Lawrence Chan, Wadih Arap, and Renata Pasqualini: https://dx.doi.org/10.1126/scitranslmed.3002621
[iii] “Cancer treatment shows promise for rapid weight loss,” Randy Seeley of the University of Cincinnati College of Medicine: https://www.latimes.com/local/la-xpm-2011-nov-10-la-he-drug-fat-loss-20111110-story.html
Adipotide Research Peptides Scientists
Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product has not been approved by the FDA for Human Use. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.